Lysophosphatidic acid and ovarian cancer: A paradigm for tumorogenesis and patient management

James R. Erickson, Yutaka Hasegawa, Xianjun Fang, Astrid Eder, Muling Mao, Tatsuro Furui, Junken Aoki, Andrew Morris, Gordon Mills

Research output: Contribution to journalArticle

25 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)63-81
Number of pages19
JournalProstaglandins and Other Lipid Mediators
Volume64
Issue number1-4
DOIs
StatePublished - Apr 1 2001
Externally publishedYes

Fingerprint

Lysosphingolipid Receptors
Lysophospholipids
Signal transduction
Tumor Biomarkers
sphingosine 1-phosphate
lysophosphatidic acid

Keywords

  • Diagnostics
  • Edg receptor
  • Lipase PCR
  • Lysophosphatidic acid
  • Ovarian cancer
  • Sphingosine-1-phosphate
  • Therapeutics
  • Tumour markers

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Pharmacology
  • Cell Biology

Cite this

Lysophosphatidic acid and ovarian cancer : A paradigm for tumorogenesis and patient management. / Erickson, James R.; Hasegawa, Yutaka; Fang, Xianjun; Eder, Astrid; Mao, Muling; Furui, Tatsuro; Aoki, Junken; Morris, Andrew; Mills, Gordon.

In: Prostaglandins and Other Lipid Mediators, Vol. 64, No. 1-4, 01.04.2001, p. 63-81.

Research output: Contribution to journalArticle

Erickson, James R. ; Hasegawa, Yutaka ; Fang, Xianjun ; Eder, Astrid ; Mao, Muling ; Furui, Tatsuro ; Aoki, Junken ; Morris, Andrew ; Mills, Gordon. / Lysophosphatidic acid and ovarian cancer : A paradigm for tumorogenesis and patient management. In: Prostaglandins and Other Lipid Mediators. 2001 ; Vol. 64, No. 1-4. pp. 63-81.
@article{31d94e91cf504b14921c22b63c5e904c,
title = "Lysophosphatidic acid and ovarian cancer: A paradigm for tumorogenesis and patient management",
keywords = "Diagnostics, Edg receptor, Lipase PCR, Lysophosphatidic acid, Ovarian cancer, Sphingosine-1-phosphate, Therapeutics, Tumour markers",
author = "Erickson, {James R.} and Yutaka Hasegawa and Xianjun Fang and Astrid Eder and Muling Mao and Tatsuro Furui and Junken Aoki and Andrew Morris and Gordon Mills",
year = "2001",
month = "4",
day = "1",
doi = "10.1016/S0090-6980(01)00100-9",
language = "English (US)",
volume = "64",
pages = "63--81",
journal = "Prostaglandins and Other Lipid Mediators",
issn = "1098-8823",
publisher = "Elsevier Inc.",
number = "1-4",

}

TY - JOUR

T1 - Lysophosphatidic acid and ovarian cancer

T2 - A paradigm for tumorogenesis and patient management

AU - Erickson, James R.

AU - Hasegawa, Yutaka

AU - Fang, Xianjun

AU - Eder, Astrid

AU - Mao, Muling

AU - Furui, Tatsuro

AU - Aoki, Junken

AU - Morris, Andrew

AU - Mills, Gordon

PY - 2001/4/1

Y1 - 2001/4/1

KW - Diagnostics

KW - Edg receptor

KW - Lipase PCR

KW - Lysophosphatidic acid

KW - Ovarian cancer

KW - Sphingosine-1-phosphate

KW - Therapeutics

KW - Tumour markers

UR - http://www.scopus.com/inward/record.url?scp=0035021984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035021984&partnerID=8YFLogxK

U2 - 10.1016/S0090-6980(01)00100-9

DO - 10.1016/S0090-6980(01)00100-9

M3 - Article

C2 - 11324708

AN - SCOPUS:0035021984

VL - 64

SP - 63

EP - 81

JO - Prostaglandins and Other Lipid Mediators

JF - Prostaglandins and Other Lipid Mediators

SN - 1098-8823

IS - 1-4

ER -